CRISPR library screens for oncology target discovery at WuXi AppTec

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Tumors acquire genetic mutations to escape immune elimination to grow and metastasize. This webinar will share case studies highlighting application of customized CRISPR/Cas9 libraries to screen for genes that control cancer cell sensitivity to target therapeutic agents and T cell-mediated elimination in vitro and in vivo. These genes are potential targets for therapeutic intervention.
Attend to discover:
• Synthetic lethal screens for mutations with chemical inhibitors or immune checkpoint blockers
• Application of in vivo CRISPR screen for metastatic drivers in cancer cells against host immunity
• Novel approaches for oncology and onco-immunology target discovery

Speaker - Yong Cang PhD, Scientific Advisor, Oncology and Immunology Unit, WuXi AppTec and Professor, Cancer Cell Biology, ShanghaiTech University (Shanghai)